PWA
SARO

Physician Wealth Advisors’s StandardAero Inc SARO Stock Holding History

Physician Wealth Advisors’s Portfolio SARO Stock Details SARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539 Buy
+18
New +$473 ﹤0.01% 2085

Other funds holding SARO

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Physician Wealth Advisors's SARO Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in StandardAero Inc (SARO) in Q2 2026: 18 shares worth $539. The stake represents ﹤0.01% of the portfolio and ranks #2085 among its holdings.

364 funds tracked by Wall St. Rank hold SARO as of Q2 2026.

  • Physician Wealth Advisors held 18 shares of StandardAero Inc worth $539 as of Q2 2026.
  • StandardAero Inc was a new Physician Wealth Advisors position in Q2 2026.
  • StandardAero Inc made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2085 holding.
  • 364 funds tracked by Wall St. Rank held StandardAero Inc as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.